Why India rejected a patent application for shorter drug-resistant TB treatment | Explained
The decision could open the door to greater generic competition, but its impact on treatment costs will depend on drug availability, pricing, and access to care
· 10/29/2026, 7:52:09 AM· 2 min read
The decision could open the door to greater generic competition, but its impact on treatment costs will depend on drug availability, pricing, and access to care
Read original story →Related stories
breaking
Airfare hikes: Keralam CM and Opposition Leader slam airlines for ‘fleecing’ NRKs
breaking
Low pressure forms in Andaman Sea after Cyclone Arnab, may affect Andhra Pradesh
breaking
Cyclone Arnab: Odisha prepares to airlift people stranded by floodwater
breaking